ATROVENT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug ATROVENT contains one active pharmaceutical ingredient (API):

1 Ipratropium bromide anhydrous
UNII J697UZ2A9J - IPRATROPIUM BROMIDE

Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol).

Read about Ipratropium

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ATROVENT HFA Inhalation aerosol, metered FDA, National Drug Code (US) MPI, US: SPL/PLR
ATROVENT Nebuliser solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R01AX03 Ipratropium bromide R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AX Other nasal preparations
Discover more medicines within R01AX03
R03BB01 Ipratropium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1542E, 4089F, 4090G, 8238N, 8671J
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 504500501178319, 504500504177313
Country: CA Health Products and Food Branch Identifier(s): 02247686
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 25.076-04-03, 29385-1-09-10
Country: EE Ravimiamet Identifier(s): 1057711, 1105940, 1567470, 1874448
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 54674, 61184, 61185, 61848
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 099486, 129817
Country: FR Base de données publique des médicaments Identifier(s): 61267669, 65756091, 66698997, 66871253, 67838060, 69720897
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 180714, 201649, 299787, 299788, 299790, 299791, 32225, 32266, 375964, 73900
Country: HK Department of Health Drug Office Identifier(s): 23564, 36372, 50402
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-119167758, HR-H-535873913
Country: IE Health Products Regulatory Authority Identifier(s): 14397, 67618, 71220
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4715
Country: JP 医薬品医療機器総合機構 Identifier(s): 2259702G2021
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004213, 1084153
Country: MT Medicines Authority Identifier(s): MA211/01001, MA211/01002, PI1438/09101A, PI908/18601A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 161M82, 189M97
Country: NL Z-Index G-Standaard Identifier(s): 13804510, 13804529, 14691159
Country: NL Z-Index G-Standaard, PRK Identifier(s): 29378, 38717, 73377
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10628
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100008205, 100114137
Country: SG Health Sciences Authority Identifier(s): 02815P, 12002P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5213074
Country: US FDA, National Drug Code Identifier(s): 0597-0087, 50090-0961
Country: ZA Health Products Regulatory Authority Identifier(s): 37/10.2.1/0273, Z/10.2.1/48

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.